Katsuya Narumi

1.3k total citations
89 papers, 954 citations indexed

About

Katsuya Narumi is a scholar working on Molecular Biology, Oncology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Katsuya Narumi has authored 89 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 28 papers in Oncology and 22 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Katsuya Narumi's work include Drug Transport and Resistance Mechanisms (24 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Amino Acid Enzymes and Metabolism (12 papers). Katsuya Narumi is often cited by papers focused on Drug Transport and Resistance Mechanisms (24 papers), Pharmacological Effects and Toxicity Studies (20 papers) and Amino Acid Enzymes and Metabolism (12 papers). Katsuya Narumi collaborates with scholars based in Japan and United States. Katsuya Narumi's co-authors include Masaki Kobayashi, Ken Iseki, Ayako Furugen, Yoshitaka Saito, Keisuke Okamoto, Takehiro Yamada, Shirou Itagaki, Jiro Ogura, Ayako Nishimura and Shotaro Sasaki and has published in prestigious journals such as PLoS ONE, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Katsuya Narumi

83 papers receiving 942 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katsuya Narumi Japan 17 320 226 166 119 119 89 954
Ayako Furugen Japan 17 327 1.0× 243 1.1× 152 0.9× 85 0.7× 117 1.0× 90 931
Robyn L. Fisher United States 24 347 1.1× 202 0.9× 130 0.8× 112 0.9× 99 0.8× 47 1.4k
Stanislav Mičuda Czechia 24 405 1.3× 472 2.1× 101 0.6× 92 0.8× 160 1.3× 97 1.5k
Jingjing Zhang China 19 369 1.2× 175 0.8× 70 0.4× 57 0.5× 85 0.7× 56 1.1k
Xiaowen Chen China 18 630 2.0× 174 0.8× 244 1.5× 111 0.9× 57 0.5× 83 1.4k
Ammar C. Al‐Rikabi Saudi Arabia 20 291 0.9× 246 1.1× 135 0.8× 320 2.7× 74 0.6× 69 1.4k
Christelle Cauffiez France 23 720 2.3× 239 1.1× 351 2.1× 99 0.8× 174 1.5× 60 1.5k
Aleksandar Dimovski North Macedonia 23 602 1.9× 151 0.7× 75 0.5× 114 1.0× 303 2.5× 134 1.9k
Gang Luo China 17 468 1.5× 176 0.8× 94 0.6× 48 0.4× 55 0.5× 60 1.3k
Jiagen Wen China 19 515 1.6× 97 0.4× 145 0.9× 108 0.9× 54 0.5× 47 1.1k

Countries citing papers authored by Katsuya Narumi

Since Specialization
Citations

This map shows the geographic impact of Katsuya Narumi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuya Narumi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuya Narumi more than expected).

Fields of papers citing papers by Katsuya Narumi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuya Narumi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuya Narumi. The network helps show where Katsuya Narumi may publish in the future.

Co-authorship network of co-authors of Katsuya Narumi

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuya Narumi. A scholar is included among the top collaborators of Katsuya Narumi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuya Narumi. Katsuya Narumi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Narumi, Katsuya, Yoshitaka Saito, Ayako Furugen, et al.. (2025). Validity and Utility of a Risk Prediction Model for Wound Infection After Lower Third Molar Surgery. Oral Diseases. 31(6). 1922–1931.
2.
Yamamoto, Yuta, Katsuya Narumi, Naoko Yamagishi, et al.. (2025). HYA ameliorated postprandial hyperglycemia in type 1 diabetes model rats with bolus insulin treatment. Acta Diabetologica. 62(8). 1337–1345. 1 indexed citations
3.
Okamoto, Keisuke, et al.. (2025). Effect of Acid Suppressants on Adverse Events of Immune Checkpoint Inhibitors Using Real-world Databases. Anticancer Research. 45(8). 3287–3293.
4.
Furugen, Ayako, et al.. (2024). Alteration in folate carrier expression via histone deacetylase inhibition in BeWo human placental choriocarcinoma cells. Toxicology in Vitro. 101. 105934–105934. 2 indexed citations
5.
Sato, Taichi, et al.. (2024). Salmon Milt Extract Suppresses Glucose Uptake by Downregulating SGLT1 and GLUT2 Expression in Caco-2 Cells. Biological and Pharmaceutical Bulletin. 47(9). 1477–1483.
6.
Yamaguchi, Atsushi, Yoshitaka Saito, Keisuke Okamoto, et al.. (2024). Association Between Multisystem Immune-related Adverse Events and Progression-free Survivals in PD-1/PD-L1 Inhibitor Monotherapy. In Vivo. 38(6). 2886–2896. 1 indexed citations
7.
Furugen, Ayako, Ayako Nishimura, Takeshi Umazume, et al.. (2024). Validated UPLC-MS/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: Application to quantify suvorexant and lemborexant in clinical samples. Journal of Pharmaceutical and Biomedical Analysis. 251. 116432–116432. 1 indexed citations
8.
Mori, Ayako, Izumi Kato, Katsuya Narumi, et al.. (2023). Quantitative analysis of communication changes in online medication counseling using the Roter Interaction System. Research in Social and Administrative Pharmacy. 20(1). 36–42. 1 indexed citations
9.
Furugen, Ayako, et al.. (2023). Effects of valproic acid on syncytialization in human placental trophoblast cell lines. Toxicology and Applied Pharmacology. 474. 116611–116611. 6 indexed citations
10.
Narumi, Katsuya, Yoshitaka Saito, Ayako Furugen, et al.. (2022). Evaluation of the strategies to reduce third‐generation oral cephalosporins in dentistry at a Japanese academic hospital: An interrupted time series analysis. Journal of Clinical Pharmacy and Therapeutics. 47(7). 1010–1019. 3 indexed citations
11.
Yamaguchi, Atsushi, Yoshitaka Saito, Keisuke Okamoto, et al.. (2021). Preexisting autoimmune disease is a risk factor for immune-related adverse events: a meta-analysis. Supportive Care in Cancer. 29(12). 7747–7753. 22 indexed citations
12.
Ishikawa, Shuhei, Masaki Kobayashi, Naoki Hashimoto, et al.. (2020). Association Between N-Desmethylclozapine and Clozapine-Induced Sialorrhea: Involvement of Increased Nocturnal Salivary Secretion via Muscarinic Receptors by N-Desmethylclozapine. Journal of Pharmacology and Experimental Therapeutics. 375(2). 376–384. 9 indexed citations
13.
Furugen, Ayako, Ayako Nishimura, Masaki Kobayashi, et al.. (2019). Quantification of eight benzodiazepines in human breastmilk and plasma by liquid-liquid extraction and liquid-chromatography tandem mass spectrometry: Application to evaluation of alprazolam transfer into breastmilk. Journal of Pharmaceutical and Biomedical Analysis. 168. 83–93. 29 indexed citations
14.
Kimura, Yuki, Masaki Kobayashi, Masaru Asari, et al.. (2018). Genetic variations in the monocarboxylate transporter genes (SLC16A1, SLC16A3, and SLC16A11) in the Japanese population. Drug Metabolism and Pharmacokinetics. 33(5). 215–218. 7 indexed citations
15.
Furugen, Ayako, Katsuya Narumi, Ayako Nishimura, et al.. (2018). Valproic acid transport in the choriocarcinoma placenta cell line JEG-3 proceeds independently of the proton-dependent transporters MCT1 and MCT4. Drug Metabolism and Pharmacokinetics. 33(6). 270–274. 4 indexed citations
16.
Kobayashi, Masaki, et al.. (2017). Identification of a selective inhibitor of human monocarboxylate transporter 4. Biochemical and Biophysical Research Communications. 495(1). 427–432. 34 indexed citations
17.
Narumi, Katsuya, Masaki Kobayashi, Ayako Furugen, et al.. (2017). Effects of proton pump inhibitors and famotidine on elimination of plasma methotrexate: Evaluation of drug–drug interactions mediated by organic anion transporter 3. Biopharmaceutics & Drug Disposition. 38(9). 501–508. 33 indexed citations
18.
Shibayama, Yoshihiko, et al.. (2015). Regorafenib Is Transported by the Organic Anion Transporter 1B1 and the Multidrug Resistance Protein 2. Biological and Pharmaceutical Bulletin. 38(4). 582–586. 29 indexed citations
19.
Kobayashi, Masaki, et al.. (2008). Bicarbonate supplementation as a preventive way in statins-induced muscle damage. Journal of Pharmacy & Pharmaceutical Sciences. 11(1). 1–1. 21 indexed citations
20.
Kobayashi, Masaki, et al.. (2008). Association between risk of myopathy and cholesterol-lowering effect: A comparison of all statins. Life Sciences. 82(17-18). 969–975. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026